Evidence map›Paper›PMID 27216421›Full record

ArticleMolecular neurodegeneration2016

Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.

Philipp A Jaeger, Kurt M Lucin, Markus Britschgi, Badri Vardarajan, Ruo-Pan Huang, Elizabeth D Kirby, Rachelle Abbey, Bradley F Boeve, Adam L Boxer, Lindsay A Farrer and 20 more

Abstract readPublished Erratum
In one paragraph

Article in Molecular neurodegeneration, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Philipp A JaegerDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. pjaeger@ucsd.edu.
Kurt M LucinDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Markus BritschgiDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Badri VardarajanDepartment of Medicine (Biomedical Genetics), Boston University Schools of Medicine, Boston, MA, USA.
Ruo-Pan HuangRayBiotech, Guangzhou, China.
Elizabeth D KirbyDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Rachelle AbbeyDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Bradley F BoeveDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Adam L BoxerDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.
Lindsay A FarrerDepartment of Medicine (Biomedical Genetics), Boston University Schools of Medicine, Boston, MA, USA.
NiCole FinchDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Neill R Graff-RadfordDepartment of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Elizabeth HeadDepartments of Pharmacology and Nutritional Sciences and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
Matan HofreeDepartment of Computer Science and Engineering, University of California, La Jolla, San Diego, CA, USA.
Ruochun HuangRayBiotech, Guangzhou, China.
Hudson JohnsDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Anna KarydasDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.
David S KnopmanDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Andrey LobodaGenetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA.
Eliezer MasliahDepartment of Pathology, University of California, La Jolla, San Diego, CA, USA.
Ramya NarasimhanDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, MN, USA.
Alexei PodtelezhnikovGenetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA.
Suraj PradhanDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Rosa RademakersDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Chung-Huan SunDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Steven G YounkinDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Bruce L MillerDepartment of Neurology, University of California San Francisco, San Francisco, CA, USA.
Trey IdekerDepartments of Bioengineering and Medicine, University of California, La Jolla, San Diego, CA, USA.
Tony Wyss-CorayDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. twc@stanford.edu.

Funding

Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
The Four Repeat Tauopathy Neuroimaging InitiativeR01AG038791 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2010 to 2020
$18.1M
Training - The Frontotemporal Lobar Degeneration Clinical Research ConsortiumU54NS092089 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BOXER, ADAM L. · 2014 to 2018
$6.4M
NIA NIH HHS P30 AG013846NIA NIH HHS R01 AG038791NINDS NIH HHS U54 NS092089
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27216421
PMCPMC4877764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.